Open AccessP893: CARFILZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE (KRD) AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS: ITALIAN, MULTICENTER, RETROSPECTIVE EXPERIENCE OUTSIDE OF CLINICAL TRIALS
Author(s) -
Martino E. A.,
Conticello C.,
Zamagni E.,
Pavone V.,
Palmieri S.,
Musso M.,
Tacchetti P.,
Mele A.,
Catlano L.,
Vigna E.,
Bruzzese A.,
Mendicino F.,
Botta C.,
Vincelli D.,
Farina G.,
Barone M.,
Cangialosi C.,
Mancuso K.,
Rizziello I.,
Rocchi S.,
Falcone A. P.,
Mele G.,
Reddiconto G.,
Garibaldi B.,
Iaccino E.,
Tripepi G.,
Di Raimondo F.,
Musto P.,
Neri A.,
Cavo M.,
Morabito F.,
Gentile M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846444.09478.3f
Subject(s) - medicine , lenalidomide , carfilzomib , discontinuation , salvage therapy , multiple myeloma , regimen , retrospective cohort study , multivariate analysis , clinical trial , surgery , oncology , chemotherapy